SetPoint Medical is focused on developing innovative therapies for chronic inflammatory diseases through the use of bioelectronic medicine. Their primary technology involves a neuromodulation approach that targets the autonomic nervous system to restore balance and reduce inflammation. This is achieved through the use of implantable devices that deliver electrical signals to specific nerves, which can modulate the immune response and potentially provide relief for conditions such as rheumatoid arthritis and Crohn's disease.

The company’s pipeline includes a range of products that leverage this neuromodulation technology, aiming to provide non-pharmacological treatment options for patients suffering from chronic inflammatory conditions. SetPoint Medical emphasizes the scientific foundation of their approach, highlighting the role of the vagus nerve in regulating immune function and the potential for their devices to offer a new paradigm in the management of these diseases. Their commitment to advancing bioelectronic therapies positions them at the forefront of a growing field that seeks to integrate technology with traditional medical practices.

United States

SetPoint Medical is a medical technology company dedicated to improving care for people living with chronic autoimmune diseases. SetPoint’s proprietary integrated neurostimulation platform is designed to activate innate anti-inflammatory pathways in the vagus nerve to reduce inflammation and restore immunologic setpoint. 

SetPoint Medical

Company Details